SenzaGen (Sweden) Analysis
| SENZA Stock | SEK 6.95 0.10 1.42% |
SenzaGen AB is overvalued with Real Value of 6.42 and Hype Value of 6.95. The main objective of SenzaGen stock analysis is to determine its intrinsic value, which is an estimate of what SenzaGen AB is worth, separate from its market price. There are two main types of SenzaGen's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect SenzaGen's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of SenzaGen's stock to identify patterns and trends that may indicate its future price movements.
The SenzaGen stock is traded in Sweden on Stockholm Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Sweden. SenzaGen is usually not traded on NationalDay, International Workers ' Day, St . John 's Day, All Saints ' Day, Christmas Eve, Christmas Day, Boxing Day, New Year 's Day, Epiphany, Good Friday, Easter Sunday, Easter Monday. SenzaGen Stock trading window is adjusted to Europe/Stockholm timezone.
SenzaGen |
SenzaGen Stock Analysis Notes
About 37.0% of the company outstanding shares are owned by corporate insiders. The book value of SenzaGen was at this time reported as 4.08. The company recorded a loss per share of 1.35. SenzaGen AB had not issued any dividends in recent years. SenzaGen AB, together with its subsidiary, markets, sells, and performs in vitro genomic allergen rapid detection sensitization tests for the screening of pharmaceutical candidates, and safety assessment of chemicals and cosmetic ingredients in Sweden and internationally. SenzaGen AB was incorporated in 2010 and is headquartered in Lund, Sweden. SenzaGen is traded on Stockholm Stock Exchange in Sweden. To find out more about SenzaGen AB contact the company at 46 4 62 75 60 00 or learn more at https://senzagen.com.SenzaGen AB Investment Alerts
| SenzaGen AB generated a negative expected return over the last 90 days | |
| SenzaGen AB has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 15.42 M. Net Loss for the year was (31.35 M) with profit before overhead, payroll, taxes, and interest of 9.45 M. | |
| SenzaGen AB has accumulated about 69.16 M in cash with (20.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.63. | |
| Roughly 37.0% of the company outstanding shares are owned by corporate insiders |
SenzaGen Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 308.55 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate SenzaGen's market, we take the total number of its shares issued and multiply it by SenzaGen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.SenzaGen Profitablity
SenzaGen's profitability indicators refer to fundamental financial ratios that showcase SenzaGen's ability to generate income relative to its revenue or operating costs. If, let's say, SenzaGen is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, SenzaGen's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of SenzaGen's profitability requires more research than a typical breakdown of SenzaGen's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (1.02) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.95) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.95. Technical Drivers
As of the 2nd of December, SenzaGen has the Coefficient Of Variation of (1,861), variance of 5.62, and Risk Adjusted Performance of (0.03). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of SenzaGen AB, as well as the relationship between them. Please validate SenzaGen AB market risk adjusted performance, variance, as well as the relationship between the Variance and value at risk to decide if SenzaGen is priced more or less accurately, providing market reflects its prevalent price of 6.95 per share.SenzaGen AB Price Movement Analysis
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. SenzaGen middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for SenzaGen AB. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
SenzaGen Outstanding Bonds
SenzaGen issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. SenzaGen AB uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most SenzaGen bonds can be classified according to their maturity, which is the date when SenzaGen AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
SenzaGen Predictive Daily Indicators
SenzaGen intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of SenzaGen stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
SenzaGen Forecast Models
SenzaGen's time-series forecasting models are one of many SenzaGen's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary SenzaGen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About SenzaGen Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how SenzaGen prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling SenzaGen shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as SenzaGen. By using and applying SenzaGen Stock analysis, traders can create a robust methodology for identifying SenzaGen entry and exit points for their positions.
SenzaGen AB, together with its subsidiary, markets, sells, and performs in vitro genomic allergen rapid detection sensitization tests for the screening of pharmaceutical candidates, and safety assessment of chemicals and cosmetic ingredients in Sweden and internationally. SenzaGen AB was incorporated in 2010 and is headquartered in Lund, Sweden. SenzaGen is traded on Stockholm Stock Exchange in Sweden.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding SenzaGen to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Fundamental Analysis Now
Fundamental AnalysisView fundamental data based on most recent published financial statements |
| All Next | Launch Module |
Additional Tools for SenzaGen Stock Analysis
When running SenzaGen's price analysis, check to measure SenzaGen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SenzaGen is operating at the current time. Most of SenzaGen's value examination focuses on studying past and present price action to predict the probability of SenzaGen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SenzaGen's price. Additionally, you may evaluate how the addition of SenzaGen to your portfolios can decrease your overall portfolio volatility.